Lipitor fails to beat Zocor in heart study (Reuters)


Reuters - High doses of Pfizer Inc.'s
cholesterol-lowering drug Lipitor failed in a high-stakes trial
to help heart attack patients significantly more than moderate
doses of Merck & Co.'s rival Zocor, researchers said on
Tuesday.